Fact CheckerSign in

NCT05427136Recruiting

Early Pulmonary Dysfunction in Childhood Cancer Patients

Prospective Multicentre Cohort Study of Early Pulmonary Dysfunction in Childhood Cancer Patients (SWISS-Pearl Study)

Source: ClinicalTrials.gov · Last updated 8 May 2026

Brief summary (registry, in English)

This longitudinal, prospective, multicentre study is to monitor lung function prospectively in childhood cancer patients after diagnosis. The impact of cancer treatment on pulmonary dysfunction non-invasively using lung function, lung imaging and breath analysis as well as clinical symptoms using a questionnaire will be assessed at different time points.

Status (registry)
Recruiting
Study type
Observational
Enrollment
140 (estimated)
First submitted
1 Jun 2022
Start date
1 Jun 2021
Primary completion date
30 Jun 2051
Lead sponsor
University Children's Hospital Basel
NCT number
NCT05427136

What you commit to

  • Study type: Observational
  • Planned participants: 140
  • From 1 Jun 2021 to the primary completion date, 30 Jun 2051
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • In addition for MRI and lung function tests:
    • Subjects who are respiratory insufficient and cannot perform a lung function test (less than 92% O2 saturation; under O2 therapy)
    • Pregnant
    • MRI measurement not possible without sedation
    • Metal (e.g. pacemaker) in the body

Other illness

  • Operation outside the chest area as only cancer treatment
  • Relapsed cancer (patients who develop relapse during the study will not be excluded)

Other

  • no signed informed consent

Who the study is looking for

  • at least one of the following cancer treatments:
    • chest radiation
    • treatment with any kind of chemotherapy
    • hematopoietic stem cell transplantation (HSCT)
    • thoracic surgery
  • consent for Childhood Cancer Registry (ChCR) registration

Age in the registry: 4 years to 22 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Children's Hospital Basel (UKBB)
Coordinator of this site? Confirm its status
BaselSwitzerlandRecruiting
Universitätsklinik für Kinderheilkunde
Coordinator of this site? Confirm its status
BernSwitzerlandRecruiting
Geneva University Hospital
Coordinator of this site? Confirm its status
GenevaSwitzerlandRecruiting
Centre Hospitalier Universitaire Vaudois Lausanne
Coordinator of this site? Confirm its status
LausanneSwitzerlandRecruiting
Universitäts-Kinderspital Zürich
Coordinator of this site? Confirm its status
ZurichSwitzerlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.